TACI mutations and disease susceptibility in patients with common variable immunodeficiency

Clinical and Experimental Immunology

Volumn 156, Issue 1, 2009, Pages 35-39

  Poodt, A E J ^a   Driessen, G J A ^b   De Klein, A ^c   Van Dongen, J J M ^c   Van Der Burg, M ^c   De Vries, E ^a  

^a JEROEN BOSCH HOSPITAL   (Netherlands)

^b SOPHIA CHILDREN S HOSPITAL   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Common variable immunodeficiency; Primary immunodeficiency; TNFRSF13B gene; Transmembrane activator and CAML interactor protein

Indexed keywords

COTRIMOXAZOLE; IMMUNOGLOBULIN; PNEUMOCOCCUS VACCINE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR;

ARTICLE; CASE REPORT; COMMON VARIABLE IMMUNODEFICIENCY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE PREDISPOSITION; ENVIRONMENTAL FACTOR; GENE; GENE MUTATION; HEREDITY; HUMAN; IMMUNOGLOBULIN A DEFICIENCY; IMMUNOGLOBULIN DEFICIENCY; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RECURRENT INFECTION; TNFRSF13B GENE; UPPER RESPIRATORY TRACT INFECTION;

ADULT; AGED; CHILD; CHILD, PRESCHOOL; COMMON VARIABLE IMMUNODEFICIENCY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; IMMUNOPHENOTYPING; LYMPHOCYTE SUBSETS; MALE; MUTATION; PEDIGREE; TRANSMEMBRANE ACTIVATOR AND CAML INTERACTOR PROTEIN;

EID: 61849135722     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2008.03863.x     Document Type: Article

References (17)

1. Wood P, Stanworth S, Burton J et al. Recognition, clinical diagnosis and management of patients with primary antibody deficiencies: a systematic review. Clin Exp Immunol 2007 149 : 410 23.
2. Quinti I, Soresina A, Spadaro G et al. Long-term follow-up and outcome of a large cohort of patients with common variable immunodeficiency. J Clin Immunol 2007 27 : 308 16.
3. Goldacker S, Warnatz K. Tackling the heterogeneity of CVID. Curr Opin Allergy Clin Immunol 2005 5 : 504 9.
4. Di Renzo M, Pasqui AL, Auteri A. Common variable immunodeficiency: a review. Clin Exp Med 2004 3 : 211 7.
5. Castigli E, Wilson SA, Garibyan L et al. TACI is mutant in common variable immunodeficiency and IgA deficiency. Nat Genet 2005 37 : 829 34.
6. Salzer U, Chapel HM, Webster AD et al. Mutations in TNFRSF13B encoding TACI are associated with common variable immunodeficiency in humans. Nat Genet 2005 37 : 820 8.
7. Grimbacher B, Hutloff A, Schlesier M et al. Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency. Nat Immunol 2003 4 : 261 8.
8. Salzer U, Maul-Pavicic A, Cunningham-Rundles C et al. ICOS deficiency in patients with common variable immunodeficiency. Clin Immunol 2004 113 : 234 40.
9. van Zelm MC, Reisli I, van der Burg M et al. An antibody-deficiency syndrome due to mutations in the CD19 gene. N Engl J Med 2006 354 : 1901 12.
10. Warnatz K, Salzer U, Gutenberger S et al. Finally found: human BAFF-R deficiency causes CVID. XIth Meeting of the European Society for Immunodeficiencies, Versailles, October 2004.
11. Kanegane H, Agematsu K, Futatani T et al. Novel mutations in a Japanese patient with CD19 deficiency. Genes Immun 2007 8 : 663 70.
12. Schaffer AA, Salzer U, Hammarstrom L et al. Deconstructing common variable immunodeficiency by genetic analysis. Curr Opin Genet Dev 2007 17 : 201 12.
13. Salzer U, Jennings S, Grimbacher B. To switch or not to switch - the opposing roles of TACI in terminal B cell differentiation. Eur J Immunol 2007 37 : 17 20.
14. Sakurai D, Kanno Y, Hase H et al. TACI attenuates antibody production costimulated by BAFF-R and CD40. Eur J Immunol 2007 37 : 110 8.
15. Pan-Hammarstrom Q, Salzer U, Du L et al. Reexamining the role of TACI coding variants in common variable immunodeficiency and selective IgA deficiency. Nat Genet 2007 39 : 429 30.
16. Hendriksen CF, van der Gun JW, Kreeftenberg JG. Combined estimation of tetanus and diphtheria antitoxin in human sera by the in vitro toxin-binding inhibition (ToBI) test. J Biol Stand 1989 17 : 191 200.
17. de Melker HE, Berbers GA, Nagelkerke NJ et al. Diphtheria antitoxin levels in the Netherlands: a population-based study. Emerg Infect Dis 1999 5 : 694 700.